chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: redness at the injection site; itching at the injection site; rash at the injection site; warmth at the injection site; soreness at the injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE RASH (rash at the injection site) and VACCINATION SITE WARMTH (warmth at the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS and OMEPRAZOLE for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). On 10-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE RASH (rash at the injection site) and VACCINATION SITE WARMTH (warmth at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE RASH (rash at the injection site) and VACCINATION SITE WARMTH (warmth at the injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications also include medication for allergy. No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: NNI
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site swelling
Clinical narrative: Fluid in his arm; If he puts his elbow down it hurts; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Fluid in his arm) and ARTHRALGIA (If he puts his elbow down it hurts) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included Pacemaker insertion (cardiac) (pacemaker, and had surgery 4 years ago), Knee replacement and Shoulder replacement. Concurrent medical conditions included Heart disease, unspecified and Artificial cardiac pacemaker user.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Fluid in his arm) and ARTHRALGIA (If he puts his elbow down it hurts). At the time of the report, VACCINATION SITE SWELLING (Fluid in his arm) and ARTHRALGIA (If he puts his elbow down it hurts) outcome was unknown.            No  concomitant medications were reported. No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Pain in extremity, Vaccination site erythema, Vaccination site photosensitivity reaction, Vaccination site pruritus
Clinical narrative: she come across with term called "COVID ARM". She read about it. She seems like that is what she had; it was very itchy; bright red patch in injection site, 8 inches long 4 inches wide; it was warmer than rest of my skin; same day achy arm lasted for day; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (same day achy arm lasted for day), INJECTION SITE WARMTH (it was warmer than rest of my skin), VACCINATION SITE PHOTOSENSITIVITY REACTION (she come across with term called "COVID ARM". She read about it. She seems like that is what she had), VACCINATION SITE PRURITUS (it was very itchy) and VACCINATION SITE ERYTHEMA (bright red patch in injection site, 8 inches long 4 inches wide) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for an unknown indication.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (same day achy arm lasted for day). On 18-Feb-2021, the patient experienced INJECTION SITE WARMTH (it was warmer than rest of my skin), VACCINATION SITE PRURITUS (it was very itchy) and VACCINATION SITE ERYTHEMA (bright red patch in injection site, 8 inches long 4 inches wide). On an unknown date, the patient experienced VACCINATION SITE PHOTOSENSITIVITY REACTION (she come across with term called "COVID ARM". She read about it. She seems like that is what she had). On 16-Feb-2021, PAIN IN EXTREMITY (same day achy arm lasted for day) had resolved. On 01-Mar-2021, INJECTION SITE WARMTH (it was warmer than rest of my skin), VACCINATION SITE PRURITUS (it was very itchy) and VACCINATION SITE ERYTHEMA (bright red patch in injection site, 8 inches long 4 inches wide) had resolved. At the time of the report, VACCINATION SITE PHOTOSENSITIVITY REACTION (she come across with term called "COVID ARM". She read about it. She seems like that is what she had) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were given. Treatment information include benadryl liquid and anti itch cream.   This case was linked to US-MODERNATX, INC.-MOD-2021-041286 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-041286:Dose 2 case
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms, Musculoskeletal stiffness
Clinical narrative: severe muscle spasm; Cannot turn the head to the right, left or up, it had a very limited range of motion; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (severe muscle spasm) and MUSCULOSKELETAL STIFFNESS (Cannot turn the head to the right, left or up, it had a very limited range of motion) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 80777 0273-99) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included LOSARTAN, ROSUVASTATIN, CLOPIDOGREL, PROPRANOLOL, ATENOLOL, FLUOXETINE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced MUSCLE SPASMS (severe muscle spasm) and MUSCULOSKELETAL STIFFNESS (Cannot turn the head to the right, left or up, it had a very limited range of motion). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and DIAZEPAM (VALIUM) for Muscle spasm, at a dose of 10 milligram. At the time of the report, MUSCLE SPASMS (severe muscle spasm) and MUSCULOSKELETAL STIFFNESS (Cannot turn the head to the right, left or up, it had a very limited range of motion) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Left arm is still a little tender; Left arm was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left arm is still a little tender) and VACCINATION SITE PAIN (Left arm was a little sore) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included Clotting disorder (Diagnosed on 2009 or 2010). Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL PALMITATE, RIBOFLAVIN, THIAMINE MONONITRATE (MULTIVITAMIN 6) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE PAIN (Left arm was a little sore). On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (Left arm is still a little tender). At the time of the report, VACCINATION SITE PAIN (Left arm is still a little tender) and VACCINATION SITE PAIN (Left arm was a little sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Pain in arms; Body aches; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arms), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arms), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Pain in arms), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Swollen Arm - Near Injection Site; Arm Pain - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swollen Arm - Near Injection Site) and VACCINATION SITE PAIN (Arm Pain - Near Injection Site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 015M20A) for COVID-19 vaccination.     Concomitant products included IBUPROFEN for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swollen Arm - Near Injection Site) and VACCINATION SITE PAIN (Arm Pain - Near Injection Site). At the time of the report, VACCINATION SITE SWELLING (Swollen Arm - Near Injection Site) and VACCINATION SITE PAIN (Arm Pain - Near Injection Site) outcome was unknown.            No treatment information was provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Vaccination site bruising, Vaccination site erythema, Vaccination site swelling
Clinical narrative: On the injection site she had a pretty wide area bruised; On the injection site she had a pretty wide area red; On the injection site she had a pretty wide area swollen; Pain from a 1 to 10 scale was 1; The area spread in red color; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (On the injection site she had a pretty wide area bruised), VACCINATION SITE ERYTHEMA (On the injection site she had a pretty wide area red), VACCINATION SITE SWELLING (On the injection site she had a pretty wide area swollen), PAIN (Pain from a 1 to 10 scale was 1) and ERYTHEMA (The area spread in red color) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LOSARTAN, NORTRIPTYLINE, METOPROLOL, OMEPRAZOLE and RALOXIFENE for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE BRUISING (On the injection site she had a pretty wide area bruised), VACCINATION SITE ERYTHEMA (On the injection site she had a pretty wide area red), VACCINATION SITE SWELLING (On the injection site she had a pretty wide area swollen), PAIN (Pain from a 1 to 10 scale was 1) and ERYTHEMA (The area spread in red color). At the time of the report, VACCINATION SITE BRUISING (On the injection site she had a pretty wide area bruised), VACCINATION SITE ERYTHEMA (On the injection site she had a pretty wide area red), VACCINATION SITE SWELLING (On the injection site she had a pretty wide area swollen), PAIN (Pain from a 1 to 10 scale was 1) and ERYTHEMA (The area spread in red color) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Limb discomfort, Pain in extremity
Clinical narrative: pain in opposite arm; Fatigue; Chills; Pain in arm; Difficult to lift arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm,), LIMB DISCOMFORT (Difficult to lift arm), PAIN IN EXTREMITY (pain in opposite arm), FATIGUE (Fatigue) and CHILLS (Chills) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm,), LIMB DISCOMFORT (Difficult to lift arm), FATIGUE (Fatigue) and CHILLS (Chills). On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in opposite arm). At the time of the report, PAIN IN EXTREMITY (Pain in arm,), LIMB DISCOMFORT (Difficult to lift arm), PAIN IN EXTREMITY (pain in opposite arm), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Throat pain; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Throat pain) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     Concomitant products included FISH OIL (OMEGA 3 [FISH OIL]) and VITAMINS NOS for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Throat pain). The patient was treated with AMOXICILLIN on 11-Mar-2021 at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (Throat pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Drug interaction
Clinical narrative: Co-administered with tetanus and rabies shot; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of DRUG INTERACTION (Co-administered with tetanus and rabies shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cat bite since 11-Mar-2021. Concomitant products included TETANUS VACCINE TOXOID (TETANUS) from 11-Mar-2021 to 11-Mar-2021, RABIES VACCINE (RABIES VACCIN) from 11-Mar-2021 to an unknown date and ANTIBIOTICS from 11-Mar-2021 to an unknown date for Animal bite.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced DRUG INTERACTION (Co-administered with tetanus and rabies shot). At the time of the report, DRUG INTERACTION (Co-administered with tetanus and rabies shot) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   After being administered the second dose of the COVID vaccine, the patient reported to the nurse that she was bit by a cat before coming to her appointment and was at urgent care, where she received a tetanus shot and was started on an antibiotic. Also, the patient's doctor's office found out that one hour after the patient received her COVID vaccine, she went to the Emergency Room, as she still had pain from the cat bite. There, she was given the "3 series" rabies shot.  Treatment information was not reported.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Received first dose and less than 18 years of age; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received first dose and less than 18 years of age) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received first dose and less than 18 years of age). On 05-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received first dose and less than 18 years of age) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old female) for mRNA-1273 (lot number 027A21A) with no associated AEs reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Little soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Little soreness at injection site) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Little soreness at injection site). At the time of the report, VACCINATION SITE PAIN (Little soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications were not reported. Treatment information was not provided.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Epistaxis, Headache, Malaise, Pain
Clinical narrative: 3 pretty nasty nosebleeds; Runny/ wet nose; Felt like he needed to curl up into a ball on bed; Massive, excruciating pains in both his arms and legs; Headache; Sore shoulder; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (3 pretty nasty nosebleeds), RHINORRHOEA (Runny/ wet nose), MALAISE (Felt like he needed to curl up into a ball on bed), PAIN (Massive, excruciating pains in both his arms and legs) and HEADACHE (Headache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, CARVEDILOL, LISINOPRIL, PREGABALIN, ATORVASTATIN and INSULIN GLARGINE (LANTUS) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced EPISTAXIS (3 pretty nasty nosebleeds), RHINORRHOEA (Runny/ wet nose), MALAISE (Felt like he needed to curl up into a ball on bed), PAIN (Massive, excruciating pains in both his arms and legs), HEADACHE (Headache) and ARTHRALGIA (Sore shoulder). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 11-Mar-2021, EPISTAXIS (3 pretty nasty nosebleeds), RHINORRHOEA (Runny/ wet nose), MALAISE (Felt like he needed to curl up into a ball on bed), PAIN (Massive, excruciating pains in both his arms and legs), HEADACHE (Headache) and ARTHRALGIA (Sore shoulder) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: 3 pretty nasty nosebleeds; Runny/ wet nose; Felt like he needed to curl up into a ball on bed; Massive, excruciating pains in both his arms and legs; Headache; Sore shoulder; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (3 pretty nasty nosebleeds), RHINORRHOEA (Runny/ wet nose), MALAISE (Felt like he needed to curl up into a ball on bed), PAIN (Massive, excruciating pains in both his arms and legs) and HEADACHE (Headache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, CARVEDILOL, LISINOPRIL, PREGABALIN, ATORVASTATIN and INSULIN GLARGINE (LANTUS) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced EPISTAXIS (3 pretty nasty nosebleeds), RHINORRHOEA (Runny/ wet nose), MALAISE (Felt like he needed to curl up into a ball on bed), PAIN (Massive, excruciating pains in both his arms and legs), HEADACHE (Headache) and ARTHRALGIA (Sore shoulder). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 11-Mar-2021, EPISTAXIS (3 pretty nasty nosebleeds), RHINORRHOEA (Runny/ wet nose), MALAISE (Felt like he needed to curl up into a ball on bed), PAIN (Massive, excruciating pains in both his arms and legs), HEADACHE (Headache) and ARTHRALGIA (Sore shoulder) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Pain in his arm; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in his arm) and PYREXIA (Low grade fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Tooth infection since an unknown date. Concomitant products included ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in his arm) and PYREXIA (Low grade fever). At the time of the report, PAIN IN EXTREMITY (Pain in his arm) and PYREXIA (Low grade fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications include antibiotics for tooth infection.   No Treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: FOLLOW-UP information received on 22-JUN-2021. Updated the events Pain in Arm and Low grade fever from unknown to Resolved.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: Headache; body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), MYALGIA (body aches) and CHILLS (chills) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced HEADACHE (Headache), MYALGIA (body aches) and CHILLS (chills). At the time of the report, HEADACHE (Headache), MYALGIA (body aches) and CHILLS (chills) outcome was unknown.            No concomitant medications were provided. No treatment medications were provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Headache, Nausea, Pain in extremity
Clinical narrative: Red rash down her arm; Red rash down her arm; Swelling of arm at injection site; Fatigue; Headaches; Nausea; Fever; Heated at injection site; Sore arm; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE WARMTH (Heated at injection site), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Red rash down her arm), RASH (Red rash down her arm) and VACCINATION SITE SWELLING (Swelling of arm at injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Heated at injection site), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE SWELLING (Swelling of arm at injection site), FATIGUE (Fatigue), HEADACHE (Headaches), NAUSEA (Nausea) and PYREXIA (Fever). On 12-Mar-2021, the patient experienced ERYTHEMA (Red rash down her arm) and RASH (Red rash down her arm). At the time of the report, VACCINATION SITE WARMTH (Heated at injection site) and VACCINATION SITE SWELLING (Swelling of arm at injection site) outcome was unknown and PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Red rash down her arm), RASH (Red rash down her arm), FATIGUE (Fatigue), HEADACHE (Headaches), NAUSEA (Nausea) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products also included Fomamox for an unknow indication.  The patient stated that she had swelling of arm, and heated at injection site. She also had a red rash down her arm, and sore for a couple of days. According to the patient, she had fatigue, headaches, nausea and fever for 2 days. No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Red rash down her arm; Red rash down her arm; Swelling of arm at injection site; Fatigue; Headaches; Nausea; Fever; Heated at injection site; Sore arm; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE WARMTH (Heated at injection site), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Red rash down her arm), RASH (Red rash down her arm) and VACCINATION SITE SWELLING (Swelling of arm at injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Heated at injection site), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE SWELLING (Swelling of arm at injection site), FATIGUE (Fatigue), HEADACHE (Headaches), NAUSEA (Nausea) and PYREXIA (Fever). On 12-Mar-2021, the patient experienced ERYTHEMA (Red rash down her arm) and RASH (Red rash down her arm). At the time of the report, VACCINATION SITE WARMTH (Heated at injection site) and VACCINATION SITE SWELLING (Swelling of arm at injection site) outcome was unknown and PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Red rash down her arm), RASH (Red rash down her arm), FATIGUE (Fatigue), HEADACHE (Headaches), NAUSEA (Nausea) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products also included Fomamox for an unknow indication.  The patient stated that she had swelling of arm, and heated at injection site. She also had a red rash down her arm, and sore for a couple of days. According to the patient, she had fatigue, headaches, nausea and fever for 2 days. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site warmth, Myalgia, Pyrexia, Vaccination site erythema
Clinical narrative: Still having a temperature of 101; vaccination site erythema; Fever; Chills; Soreness in injection site; Warm to touch; Muscle aches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), VACCINATION SITE PAIN (Soreness in injection site), INJECTION SITE WARMTH (Warm to touch) and MYALGIA (Muscle aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse reaction.    On 11-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 11-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), VACCINATION SITE PAIN (Soreness in injection site), INJECTION SITE WARMTH (Warm to touch), MYALGIA (Muscle aches) and ERYTHEMA (Red). On an unknown date, the patient experienced PYREXIA (Still having a temperature of 101). At the time of the report, PYREXIA (Fever), CHILLS (Chills), INJECTION SITE WARMTH (Warm to touch), MYALGIA (Muscle aches), PYREXIA (Still having a temperature of 101) and ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Still having a temperature of 101; vaccination site erythema; Fever; Chills; Soreness in injection site; Warm to touch; Muscle aches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), VACCINATION SITE PAIN (Soreness in injection site), INJECTION SITE WARMTH (Warm to touch) and MYALGIA (Muscle aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse reaction.    On 11-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 11-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), VACCINATION SITE PAIN (Soreness in injection site), INJECTION SITE WARMTH (Warm to touch), MYALGIA (Muscle aches) and ERYTHEMA (Red). On an unknown date, the patient experienced PYREXIA (Still having a temperature of 101). At the time of the report, PYREXIA (Fever), CHILLS (Chills), INJECTION SITE WARMTH (Warm to touch), MYALGIA (Muscle aches), PYREXIA (Still having a temperature of 101) and ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: 100.2 temperature; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (100.2 temperature) and CHILLS (Chills) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D32M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (100.2 temperature) and CHILLS (Chills). At the time of the report, PYREXIA (100.2 temperature) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.2 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash all over her body; A spontaneous report was received from a consumer concerning a 59-years-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced rash all over her body/ rash.  The patient's medical history included high blood pressure. Products known to have been used by the patient, within two weeks prior to the event, included lisinopril.  On 25 Feb 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 031L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 25 Feb 2021, the patient experienced  allergic reaction of rash all over her body.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not provided.   The outcome of event rash all over her body was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urine present
Clinical narrative: Blood in the urine; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD URINE PRESENT (Blood in the urine) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY ELLIPTA), SALBUTAMOL (ALBUTEROL HFA) and PRAVASTATIN for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD URINE PRESENT (Blood in the urine). The patient was treated with NITROFURANTOIN at an unspecified dose and frequency. At the time of the report, BLOOD URINE PRESENT (Blood in the urine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient went to healthcare professional for urine analysis.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013620A) for COVID-19 vaccination.     No medical history was reported.     On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown. Not applicable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. Treatment Shingles medications The patient had the second dose scheduled on 14-Feb-2021. A week prior of the administration of the second dose, the patient  developed shingles and received shingles medications as a treatment. The vaccination provider told her to not receive the vaccine until the medication was over.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash around neck and chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash around neck and chest) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash around neck and chest). At the time of the report, RASH (rash around neck and chest) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.  No concomitant medication was reported No treatment medication was reported
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Chills; Fevers; Headaches; A spontaneous report was received from a 63-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills, fevers/pyrexia and headaches.  The patient's medical history included Rheumatoid arthritis. Concomitant product use was not provided.  On unknown date, prior to the onset of the events, the patient received first of two planned doses of mRNA-1273 (lot/batch: 030M20A) Intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, after receiving the first dose, the patient experienced chills, fevers and headaches.Symptoms improved after about 36 hours. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, chills, fevers and headaches was resolving at the time of this report.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: arm hot at injection site; arm red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (arm hot at injection site) and INJECTION SITE ERYTHEMA (arm red at injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced INJECTION SITE WARMTH (arm hot at injection site) and INJECTION SITE ERYTHEMA (arm red at injection site). At the time of the report, INJECTION SITE WARMTH (arm hot at injection site) and INJECTION SITE ERYTHEMA (arm red at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter. Treatment of events was not reported.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: ache in the upper arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (ache in the upper arm) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol, Blood pressure high and Platelets abnormal. Concomitant products included MAGNESIUM, CALCIUM and VITAMIN D NOS for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (ache in the upper arm). At the time of the report, PAIN IN EXTREMITY (ache in the upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Additional concomitant medications reported since an unknown start date included medicines for cholesterol, platelet and blood pressure indications.  Treatment of events was not reported though the patient did call to confirm if she could take acetaminophen (Tylenol).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Pain in her right knee is worse after receiving the Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain in her right knee is worse after receiving the Moderna COVID-19 vaccine) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 032M204) for COVID-19 vaccination.     The patient's past medical history included Arthritis.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced ARTHRALGIA (Pain in her right knee is worse after receiving the Moderna COVID-19 vaccine). At the time of the report, ARTHRALGIA (Pain in her right knee is worse after receiving the Moderna COVID-19 vaccine) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Fatigue, Headache, Hypoaesthesia
Clinical narrative: Last week, had rash on right arm, light red, circular in nature; sore arm  felt like someone beating my arm in a fight; ingers on both hands felt numb and tingling for couple of minutes; stomach was off; absolutely had no energy; felt pretty lousy after the first dose; headachy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm  felt like someone beating my arm in a fight), HYPOAESTHESIA (ingers on both hands felt numb and tingling for couple of minutes), ABDOMINAL DISCOMFORT (stomach was off), ASTHENIA (absolutely had no energy) and FATIGUE (felt pretty lousy after the first dose) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sjogren's syndrome, Hashimoto's disease, Joint inflammation, Osteoporosis and Osteoarthritis. Concomitant products included COLECALCIFEROL (vitamin D), FOLIC ACID, vitamin c and folic acid and CALCIUM CITRATE for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm  felt like someone beating my arm in a fight), HYPOAESTHESIA (ingers on both hands felt numb and tingling for couple of minutes), ABDOMINAL DISCOMFORT (stomach was off), ASTHENIA (absolutely had no energy), FATIGUE (felt pretty lousy after the first dose) and HEADACHE (headachy). On an unknown date, the patient experienced RASH (Last week, had rash on right arm, light red, circular in nature). On 27-Feb-2021, HYPOAESTHESIA (ingers on both hands felt numb and tingling for couple of minutes) had resolved. On 01-Mar-2021, PAIN IN EXTREMITY (sore arm  felt like someone beating my arm in a fight), ABDOMINAL DISCOMFORT (stomach was off), ASTHENIA (absolutely had no energy), FATIGUE (felt pretty lousy after the first dose) and HEADACHE (headachy) had resolved. At the time of the report, RASH (Last week, had rash on right arm, light red, circular in nature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication details was reported.   This case was linked to MOD-2021-060899 (Patient Link).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: Last week, had rash on right arm, light red, circular in nature; sore arm  felt like someone beating my arm in a fight; ingers on both hands felt numb and tingling for couple of minutes; stomach was off; absolutely had no energy; felt pretty lousy after the first dose; headachy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm  felt like someone beating my arm in a fight), HYPOAESTHESIA (ingers on both hands felt numb and tingling for couple of minutes), ABDOMINAL DISCOMFORT (stomach was off), ASTHENIA (absolutely had no energy) and FATIGUE (felt pretty lousy after the first dose) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sjogren's syndrome, Hashimoto's disease, Joint inflammation, Osteoporosis and Osteoarthritis. Concomitant products included COLECALCIFEROL (vitamin D), FOLIC ACID, vitamin c and folic acid and CALCIUM CITRATE for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm  felt like someone beating my arm in a fight), HYPOAESTHESIA (ingers on both hands felt numb and tingling for couple of minutes), ABDOMINAL DISCOMFORT (stomach was off), ASTHENIA (absolutely had no energy), FATIGUE (felt pretty lousy after the first dose) and HEADACHE (headachy). On an unknown date, the patient experienced RASH (Last week, had rash on right arm, light red, circular in nature). On 27-Feb-2021, HYPOAESTHESIA (ingers on both hands felt numb and tingling for couple of minutes) had resolved. On 01-Mar-2021, PAIN IN EXTREMITY (sore arm  felt like someone beating my arm in a fight), ABDOMINAL DISCOMFORT (stomach was off), ASTHENIA (absolutely had no energy), FATIGUE (felt pretty lousy after the first dose) and HEADACHE (headachy) had resolved. At the time of the report, RASH (Last week, had rash on right arm, light red, circular in nature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication details was reported.   This case was linked to MOD-2021-060899 (Patient Link).